8 results
10-K
2021 FY
CADL
Candel Therapeutics Inc
29 Mar 22
Annual report
8:46am
that T cells can be unleashed to attack cancer cells and that profound clinical benefit can be achieved, but this benefit accrues only to a minority
424B4
CADL
Candel Therapeutics Inc
28 Jul 21
Prospectus supplement with pricing info
4:02pm
can be unleashed to attack cancer cells and that profound clinical benefit can be achieved, but this benefit accrues only to a minority of patients
S-1/A
7kcy415f2k7qjz
16 Jul 21
IPO registration (amended)
6:07am
S-1
3e5ww
25 Jun 21
IPO registration
5:28pm
DRS/A
edap0h59btnxx aeu
31 Mar 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next